BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Voyager Sinks as Sanofi Genzyme Opts Out of Parkinson’s Gene Therapy Program

  Shares of Voyager have fallen more than 12 percent in premarket trading after Sanofi Genzyme walked away from its $845M gene therapy treatment for Parkinson’s disease.

  October 31, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Grail CSO Exits to Join Bay Area VC Firm Foresite Capital

  Vikram Bajaj joined Grail only a year ago.

  October 31, 2017

   · 

  1 min read
• 

  Deals

  3 Biotechs Bloodied Celgene Could Take Out

  Investors and analysts are wondering if the company should buy a biotech to bolster its pipeline and bottom line.

  October 31, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Lone Star Bio

  Houston Medtech Firm Corinnova Scores $6.1M

  Corinnova’s CEO says the company has developed a device called EpicHeart to tackle heart failure.

  October 31, 2017

   · 

  1 min read
• Week in Review: China Resources Pharma Files for $369 Million China Life Science Investment Fund

  China Resources Pharma announced plans to raise $368.5 million for a China life science investment fund.

  October 31, 2017

   · 

  1 min read
• 

  Drug Development

  Indivior Explodes After the FDA Panel Backs Opioid Addiction Drug

  The FDA’s Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee voted 18 to 1 to recommend Indivior’s RBP-6000 to treat opioid use disorder.

  October 31, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte

  Astra and Incyte are pushing forward on the development of immunotherapy combination treatments.

  October 31, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  X-Spine Systems to Shut Down, Lays Off 54 Employees

  X-Spine is shutting down its Ohio facility and terminating the employees between December and February 2018.

  October 31, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  6 Biotechs Facing Make-or-Break FDA PDUFA Catalysts in November

  Here’s a closer look at six drugs facing FDA decisions in November.

  October 31, 2017

   · 

  2 min read

   · 

  Mark Terry
• New Analyses Reinforce Hemodynamic Benefits of Medtronic Evolut TAVR Platform in Intermediate Risk Aortic Stenosis Patients

  Data of the FORWARD ‘real-world’ study were presented at the Transcatheter Cardiovascular Therapeutics Annual Meeting.

  October 31, 2017

   · 

  3 min read